|
16.07.19
|
|
Neurocrine Biosciences Outperform
|
Oppenheimer & Co. Inc.
|
|
21.11.18
|
|
Neurocrine Biosciences Buy
|
Canaccord Adams
|
|
07.08.18
|
|
Neurocrine Biosciences Buy
|
Stifel, Nicolaus & Co., Inc.
|
|
22.02.18
|
|
Neurocrine Biosciences Buy
|
Needham & Company, LLC
|
|
02.11.17
|
|
Neurocrine Biosciences Buy
|
H.C. Wainwright & Co.
|
|
04.08.17
|
|
Neurocrine Biosciences Outperform
|
BMO Capital Markets
|
|
10.05.17
|
|
Neurocrine Biosciences Buy
|
H.C. Wainwright & Co.
|
|
03.11.16
|
|
Neurocrine Biosciences Buy
|
Deutsche Bank AG
|
|
|
|
18.10.16
|
|
Neurocrine Biosciences Buy
|
Needham & Company, LLC
|
|
29.06.16
|
|
Neurocrine Biosciences Buy
|
H.C. Wainwright & Co.
|
|
08.04.16
|
|
Neurocrine Biosciences Outperform
|
BMO Capital Markets
|
|
04.03.15
|
|
Neurocrine Biosciences overweight
|
Barclays Capital
|
|
10.02.15
|
|
Neurocrine Biosciences Buy
|
Deutsche Bank AG
|
|
05.02.15
|
|
Neurocrine Biosciences Outperform
|
RBC Capital Markets
|
|
09.01.15
|
|
Neurocrine Biosciences Buy
|
Deutsche Bank AG
|
|
21.06.12
|
|
Neurocrine Biosciences buy
|
ROTH Capital Partners, LLC
|
|
09.01.09
|
|
Neurocrine Biosciences neutral
|
UBS AG
|
|
11.11.08
|
|
Neurocrine Biosciences neutral
|
UBS AG
|
|
31.10.08
|
|
Neurocrine Biosciences neutral
|
Piper Jaffray & Co.
|
|
04.09.08
|
|
Neurocrine Biosciences neutral
|
UBS AG
|
|
18.12.07
|
|
Neurocrine Biosciences overweight
|
Lehman Brothers Inc.
|
|
14.12.07
|
|
Neurocrine Biosciences underperform
|
Bear Stearns Companies Inc.
|
|
14.12.07
|
|
Neurocrine Biosciences neutral
|
UBS AG
|
|
14.12.07
|
|
Neurocrine Biosciences sell
|
Piper Jaffray & Co.
|
|
14.12.07
|
|
Neurocrine Biosciences underperform
|
Jefferies & Company Inc.
|
|
11.10.07
|
|
Neurocrine Biosciences market perform
|
Wachovia Sec
|
|
02.08.07
|
|
Neurocrine Biosciences overweight
|
Lehman Brothers
|
|
18.01.07
|
|
Neurocrine Biosciences overweight
|
Lehman Brothers
|
|
08.01.07
|
|
Neurocrine Biosciences neutral
|
UBS
|
|
05.01.07
|
|
Neurocrine Biosciences Neutral
|
UBS
|
|
29.06.06
|
|
Neurocrine Biosciences reduce
|
UBS
|
|
26.06.06
|
|
Neurocrine Biosciences equal weight
|
Lehman Brothers
|
|
23.06.06
|
|
Neurocrine Biosciences hold
|
A.G. Edwards & Sons
|
|
23.06.06
|
|
Neurocrine Biosciences underweight
|
Morgan Stanley
|
|
23.06.06
|
|
Neurocrine Biosciences sell
|
Citigroup
|
|
16.06.06
|
|
Neurocrine Biosciences underperform
|
Leerink Swann
|
|
16.06.06
|
|
Neurocrine Biosciences underperform
|
Robert W. Baird
|
|
16.06.06
|
|
Neurocrine Biosciences Underperform
|
Leerink Swann
|
|
18.05.06
|
|
Neurocrine Biosciences underperform
|
Jefferies & Co
|
|
18.05.06
|
|
Neurocrine Biosciences equal weight
|
Lehman Brothers
|
|
08.05.06
|
|
Neurocrine Biosciences buy
|
A.G. Edwards & Sons
|
|
12.01.06
|
|
Neurocrine Biosciences market perform
|
Leerink Swann
|
|
11.01.06
|
|
Neurocrine Biosciences outperform
|
Piper Jaffray
|
|
05.01.06
|
|
Neurocrine Biosciences outperform
|
Credit Suisse First Boston
|
|
08.12.05
|
|
Neurocrine Biosciences hold
|
Jefferies & Co
|
|
08.12.05
|
|
Neurocrine Biosciences Hold
|
Jefferies & Co
|
|
08.12.05
|
|
Neurocrine Biosciences hold
|
Citigroup
|
|
02.12.05
|
|
Neurocrine Biosciences neutral
|
Robert W. Baird
|
|
14.10.05
|
|
Neurocrine Biosciences overweight
|
Prudential Financial
|
|
14.10.05
|
|
Neurocrine Biosciences Overweight
|
Prudential Securities
|
